Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

24 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Adhesin presentation in bacteria requires molecular chaperones and ushers.
Jones CH, Jacob-Dubuisson F, Dodson K, Kuehn M, Slonim L, Striker R, Hultgren SJ. Jones CH, et al. Among authors: slonim l. Infect Immun. 1992 Nov;60(11):4445-51. doi: 10.1128/iai.60.11.4445-4451.1992. Infect Immun. 1992. PMID: 1356928 Free PMC article. Review. No abstract available.
Haploidentical Transplant with Post-Transplant Cyclophosphamide for Acute Myeloid Leukaemia and Myelodysplastic Syndromes Patients: The Role of Previous Lines of Therapy.
Avenoso D, Serpenti F, Slonim LB, Bouziana S, Dazzi F, Hannah G, Kenyon M, Mehra V, Kulasekararaj A, Krishamurthy P, Shah MN, Lionel S, Pagliuca A, Potter V. Avenoso D, et al. Among authors: slonim lb. Mediterr J Hematol Infect Dis. 2024 Jan 1;16(1):e2024002. doi: 10.4084/MJHID.2024.002. eCollection 2024. Mediterr J Hematol Infect Dis. 2024. PMID: 38223487 Free PMC article.
Myeloablative Dose of Busulfan and Fludarabine Combined with In Vivo T Cell Depletion Is Safe and Effective Conditioning for Acute Myeloid Leukemia and Myelodysplastic Syndrome Patients.
Avenoso D, Mehra V, Slonim LB, de Farias M, Alshehri H, Bouziana S, Krishnamurthy P, Kulasekararaj A, Dazzi F, Wood H, Kenyon M, Leung YT, Anteh S, Shah MN, Hannah G, Serpenti F, Gameil A, Bourlon C, Dragoi OD, Pagliuca A, Potter V. Avenoso D, et al. Among authors: slonim lb. Transplant Cell Ther. 2023 Nov;29(11):698.e1-698.e6. doi: 10.1016/j.jtct.2023.08.012. Epub 2023 Aug 12. Transplant Cell Ther. 2023. PMID: 37579918 Free article.
Sequential pembrolizumab and AVD are highly effective at any PD-L1 expression level in untreated Hodgkin lymphoma.
Allen PB, Lu X, Chen Q, O'Shea K, Chmiel JS, Slonim LB, Sukhanova M, Savas H, Evens AM, Advani R, Pro B, Karmali R, Palmer B, Bayer RA, Eisner RM, Mou E, Dillehay G, Gordon LI, Winter JN. Allen PB, et al. Among authors: slonim lb. Blood Adv. 2023 Jun 27;7(12):2670-2676. doi: 10.1182/bloodadvances.2022008116. Blood Adv. 2023. PMID: 36083129 Free PMC article.
24 results